logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Consun Pharmaceutical (01681.HK) repurchased 193,000 shares for HK$2.528 million on September 16.

date
16/09/2026
Zhito Finance APP News: Consun Pharmaceutical (01681.HK) announced that on September 16, 2026, it spent HK$2.528 million to repurchase 193,000 shares.
Latest
2 m ago
Kaili New Materials (300234.SZ) controlling shareholder and its concerted parties plan to transfer 10.3% of the company's shares to Luzhou Jinkai.
2 m ago
Jinmaoyuan Environmental Protection (06805.HK) spent HKD 1.0435 million to repurchase 350,000 shares on September 16.
3 m ago
Salesforce (CRM.N) will bring OpenAI models into government environments.
4 m ago
Salesforce (CRM.N) expands Missionforce government services capabilities.
5 m ago
U.S. Treasury yields held their declines after the release of retail sales and import-export price data.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.